Murray Stewart, Tracy http://orcid.org/0000-0001-8679-6414
Von Hoff, Daniel
Fitzgerald, Michael
Marton, Laurence J.
Becerra, Carlos H. Roberto
Boyd, Thomas E.
Conkling, Paul R.
Garbo, Lawrence E.
Jotte, Robert M.
Richards, Donald A.
Smith, David A.
Stephenson, Joe J. Jr.
Vogelzang, Nicholas J.
Wu, Hillary H.
Casero, Robert A. Jr.
Funding for this research was provided by:
National Cancer Institute (R01CA204345, R01CA235863)
Article History
Received: 17 August 2020
Accepted: 3 November 2020
First Online: 19 November 2020
Compliance with ethical standards
:
: During the development of PG-11047, in vitro and in vivo preclinical studies of PG-11047 and related analogues were funded in part by a gift to the laboratory of RAC by Cellgate, Inc., the previous owner of PG-11047.
: All participants provided written informed consent that was approved by the Institutional Review Boards (IRBs) associated with the study site prior to study initiation. The trial was conducted in accordance with the IRB-approved protocol and amendments, Good Clinical Practice guidelines, and the Declaration of Helsinki.